Subcutaneous Ocrelizumab in Patients With Multiple Sclerosis: Results of the Phase 3 OCARINA II Study
皮下注射奥克瑞珠单抗治疗多发性硬化症患者:OCARINA II 期 3 期研究结果
期刊:Neurology
影响因子:8.5
doi:10.1212/WNL.0000000000213574
Newsome, Scott D; Krzystanek, Ewa; Selmaj, Krzysztof W; Dufek, Michal; Goldstick, Lawrence; Pozzilli, Carlo; Figueiredo, Catarina; Townsend, Ben; Kletzl, Heidemarie; Bortolami, Oscar; Zecevic, Dusanka; Giacobino, Caroline; Clinch, Susanne; Shen, Yun-An; Bhullar, Gurpreet Deol; Schneble, Hans-Martin; Centonze, Diego